---
$id: https://graph.org.ai/products/commodity/51112609
$type: Product
source: UNSPSC
code: "51112609"
title: "Neptamustine or pentamustine"
class: "51112600"
classTitle: "Alkylating agent nitrosourea compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neptamustine or pentamustine

**UNSPSC Code**: 51112609
**Class**: [Alkylating agent nitrosourea compounds](Alkylating agent nitrosourea compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nitrosourea compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VB67O9FBGM. European Medicines Agency schedules Neptamustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09201MIG. Neptamustine generally arises in the molecular formula C8H16CLN3O2. The term NEPTAMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) NEPTAMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Neptamustine or pentamustine bears US NLM identifiers UMLS ID C1882315 and NCI Concept Code C66341. SMILES: CLCCN(N=O)C(=O)NCC(C)(C)C.

